四磨汤对功能性消化不良患者的临床疗效及模型小鼠Ghrelin、GHSR表达的影响
|
摘要
1目的
探讨四磨汤对餐后不适综合征(肝脾气滞证)FD患者的临床疗效、心理量表评分及血浆Ghrelin的影响；同时,观察四磨汤对慢性应激小鼠胃肠功能、胃肠道和脑区Ghrelin及其受体表达的影响,以期为中医肝脾相关理论的现代生物学基础是脑肠轴失衡的假说,寻找临床和实验依据。
2方法
2.1应用随机、双盲、双模拟法,选取餐后不适综合征FD患者(中医诊断为肝脾气滞证痞满者),予四磨汤治疗,观察治疗前后患者症状、胃肠排空功能、血浆Ghrelin水平及SAS、SDS评分变化情况,评价其疗效。
2.2采取不可预知的慢性应激法制备胃肠功能障碍小鼠模型,予四磨汤干预,观察治疗前后模型小鼠的一般状况、饮食量、体重的变化,研究四磨汤对模型小鼠胃排空率、小肠推进率和胃动素、胃泌素、胃肠道和脑区Ghrelin及其受体mRNA表达的影响。
3结果
3.1临床研究
两组患者总有效率比较差异无统计学意义(P>0.05)。但总显效率治疗组优于对照组(P<0.05)。证候中的嗳气反酸、心烦易怒,喜叹息,便秘的症状疗效,治疗组优于对照组(P<0.05)。
两组患者胃排空率及血浆Ghrelin水平均明显提高,两组之间无显著性差异(P>0.05)。治疗组治疗后Ghrelin水平与正常组比较(P<0.05),而对照组治疗后与正常组比较仍明显减低(P<0.01)。
FD患者中,伴有焦虑症状者占31.67%,伴有抑郁症状者占25%。FD患者的SAS、SDS评分与我国常模比较均明显升高(P<0.01)。FD病情重度者伴焦虑、抑郁的人数明显高于病情中度者(P<0.01)。四磨汤可以降低患者SAS、SDS评分,两组之间比较没有统计学意义(P>0.05),但治疗组治疗后SAS标准分与治疗前比较P<0.05。
3.2实验研究
不可预知的慢性应激可使小鼠食量、体重、胃排空率、小肠推进功能明显下降(P<0.01),胃肠组织无明显病理改变。模型小鼠血清MTL、GAS、Ghrelin含量明显降低(P<0.01),脑、胃、十二指肠Ghrelin及其受体GHSR mRNA的表达明显减少(P<0.01)
四磨汤组和多潘立酮组食量、体重均明显增加(P<0.01),胃排空、小肠推进功能均得以恢复(P<0.05),两组血清MTL、GAS、Ghrelin含量均升高(P<0.05),两组之间比较差异无统计学意义(P>0.05)。
脑、胃组织中Ghrelin及其受体GHSR mRNA阳性表达方面,四磨汤组与模型组比较显著增多(P<0.01),多潘立酮组与模拟组比较增多(P<0.05)。在十二指肠Ghrelin及其受体GHSR mRNA阳性表达方面,两组与模型组比较均升高(P<0.05)。四磨汤组与多潘立酮组相比,上述指标差异均无统计学意义(P>0.05)。
结论
1.四磨汤能显著改善餐后不适综合征FD患者的临床症状,促进胃排空,四磨汤组总疗效与多潘立酮组相当。
2.FD患者血浆Ghrel in的含量显著降低,并与病情严重程度呈负相关。四磨汤可以调节患者血浆Ghrelin水平,稍优于多潘立酮组。
3.FD伴有焦虑、抑郁情况明显高于普通人群,消化不良症状程度与SAS、SDS评分呈正相关。四磨汤可以降低患者SAS、SDS评分,对患者焦虑状况有所改善,但无明显改善抑郁状况的作用。
4.四磨汤能促进慢性应激小鼠胃排空率、小肠推进率,增加不可预知慢性应激小鼠食量、体重,能调节血中MTL、GAS、Ghrel in水平及脑、胃、十二指肠Ghrelin及其受体GHSR mRNA的表达。
5.四磨汤治疗FD的机制可能是通过调节脑肠肽的水平变化,协调脑肠轴的平衡而实现的,这也为中医肝脾相关理论的现代生物学基础是脑肠轴失衡的假说提供了证据。
Objective:
To study the clinical curative effect of Simo Decoction on patients with Postprandial distress syndrome of functional dyspepsia.Explore spirit psychological factors and FD relationship,and from brain gut peptide, brain-gut interaction, brain-gut axis imbalances, discusses the mechanism. Simultaneously,to observe how Simo Decoction affect the chronic stress of gastrointestinal function of mice, gastrointestinal tract and Ghrelin and its receptor expression in brain regions.The thesis provide Chinese medicine, liver and spleen related theory of modern biological basis with brain-gut axis imbalances hypothesis, esearching clinical and experimental basis.
Methods:
1.Patients with postprandial distress syndrome of functional dyspepsia being selected, are randomly divided into treatment group and control group, correspondly given Simo Decoction, and then observe the patients'gastrointestinal emptying-function, symptoms and brain gut peptide, levels of plasma Ghrelin before and after treatment to evaluate their curative effect.
2.Applying the model group of gastrointestinal-emptying impediment by the method of unpredictable chronic stress, next,randomly dividing the mice into model group, Simo Decoction group, domperidone group,and then respectively giving different treatment to observe the situation of animals'carbonpowder-promoting,the residual rate in stomach, to examinate the levels of motilin, gastrin, Ghrelin in serum, Ghrelin and GHSR expression in the stomach, brain and small intestine.
Results:
1. Clinical Research
In two groups of patients with total efficiency compare difference not to have statistical significance (P>0.05)。But the markedly effective rate in treatment group than in control group (P<0.05). For the healing effect of the symptoms of belching and acid reflux, restlessness,regular sigh, constipation, the treatment group is superior to control group(P<0.05) there is no statistical significance between the levels of Ghrelin in plasma and gastric evacuation rate (P>0.05).The comparison between the treatment group after being treated and normal group in respect of the level of Ghrelin (P<0.05),after being treated,the control group is markedly deduced,comparing with normal group (P<0.01). FD patients, with anxiety symptoms and depressive symptoms account for31.67%and25%respectively. Compared with China's general population standard,the grade of SAS and SDS for patients is significantly higher (P<0.01).The number of patients with serious condition accompanying anxiety and depression apparently higher than those with moderate condition. After treatment,the grade of SAS and SDS for patients is decreased and the comparison between the two groups exist no statistical significance (P>0.05). But for the treatment groups, the comparison between after and before treatment in aspect of standard score of SAS P<0.05
2.Experimental Study
Unpredictable chronic stress can set appetite, body mass and the rate of gastric emptying, intestinal propulsive function deducing apparently.(P <0.01)There is no significant pathology change in gastrointestinal tissue. The contents of MTL, GAS, Ghrelin in experimental mice serum(P<0.01) and brain, stomach and duodenum Ghrelin and GHSR mRNA lower distinctly(P<0.01). For the indicators of Simo Decoction group and domperidone group,appetite and weight significantly grow(P<0.01). Gastric emptying, intestinal propulsive function can be restored(P<0.05).The contents of MTL, GAS, Ghrelin of serum cause an increase.The two groups exist no statistical significance (P>0.05). In positive expression aspect of Ghrelin and its receptor GHSR mRNA in brain and gastric tissue, Simo Decoction group compared with the model group increased significantly(P<0.01),domperidone group compared with the model group increase (P<0.05). In positive expression aspect of Ghrelin and its receptor GHSR mRNA in duodenum tissue, Two groups group compared with model are elevated (P<0.05), Simo decoction group and domperidone groups exist no statistical significance (P>0.05).
Conclusion:
1.Simo Decoction can effectively improve symptoms and gastrointestinal-emptying of FD patients.Clinical efficacy of Simo Decoction is equivalent to Domperidone groups.
2.The Ghrelin content of plasma in FD patients is apparently reduced and assumes the inverse correlation with the condition order of severity. Simo Decoction can adjust patients'plasma Ghrelin levels, slightly better than Domperidone group.
3. FD patients with anxiety, depression significantly higher than the normal people, the extent of dyspepsia symptoms and the grade of SAS and SDS are positively correlated. Simo Decoction reduce the grade of SAS and SDS, improve anxiety condition but there is no improvement for depression situations.
4.Simo Decoction not only can promote the rate of gastric emptying in chronic stress of mice and increase appetite,weight for unpredictable chronic stress of mice but also adjust the level of MTL, GAS, Ghrelin of serum and brain, stomach, and small intestine Ghrelin and GHSR mRNA expressions.
5. The possibility of the treatment of FD with the mechanism of Simo Decoction could be achieved by adjusting the level of braingut peptide and balance of brain-gut axis.Furthermore,it provide Chinese medicine, liver and spleen related theory of modern biological basis with brain-gut axis imbalances hypothesis.
探讨四磨汤对餐后不适综合征(肝脾气滞证)FD患者的临床疗效、心理量表评分及血浆Ghrelin的影响；同时,观察四磨汤对慢性应激小鼠胃肠功能、胃肠道和脑区Ghrelin及其受体表达的影响,以期为中医肝脾相关理论的现代生物学基础是脑肠轴失衡的假说,寻找临床和实验依据。
2方法
2.1应用随机、双盲、双模拟法,选取餐后不适综合征FD患者(中医诊断为肝脾气滞证痞满者),予四磨汤治疗,观察治疗前后患者症状、胃肠排空功能、血浆Ghrelin水平及SAS、SDS评分变化情况,评价其疗效。
2.2采取不可预知的慢性应激法制备胃肠功能障碍小鼠模型,予四磨汤干预,观察治疗前后模型小鼠的一般状况、饮食量、体重的变化,研究四磨汤对模型小鼠胃排空率、小肠推进率和胃动素、胃泌素、胃肠道和脑区Ghrelin及其受体mRNA表达的影响。
3结果
3.1临床研究
两组患者总有效率比较差异无统计学意义(P>0.05)。但总显效率治疗组优于对照组(P<0.05)。证候中的嗳气反酸、心烦易怒,喜叹息,便秘的症状疗效,治疗组优于对照组(P<0.05)。
两组患者胃排空率及血浆Ghrelin水平均明显提高,两组之间无显著性差异(P>0.05)。治疗组治疗后Ghrelin水平与正常组比较(P<0.05),而对照组治疗后与正常组比较仍明显减低(P<0.01)。
FD患者中,伴有焦虑症状者占31.67%,伴有抑郁症状者占25%。FD患者的SAS、SDS评分与我国常模比较均明显升高(P<0.01)。FD病情重度者伴焦虑、抑郁的人数明显高于病情中度者(P<0.01)。四磨汤可以降低患者SAS、SDS评分,两组之间比较没有统计学意义(P>0.05),但治疗组治疗后SAS标准分与治疗前比较P<0.05。
3.2实验研究
不可预知的慢性应激可使小鼠食量、体重、胃排空率、小肠推进功能明显下降(P<0.01),胃肠组织无明显病理改变。模型小鼠血清MTL、GAS、Ghrelin含量明显降低(P<0.01),脑、胃、十二指肠Ghrelin及其受体GHSR mRNA的表达明显减少(P<0.01)
四磨汤组和多潘立酮组食量、体重均明显增加(P<0.01),胃排空、小肠推进功能均得以恢复(P<0.05),两组血清MTL、GAS、Ghrelin含量均升高(P<0.05),两组之间比较差异无统计学意义(P>0.05)。
脑、胃组织中Ghrelin及其受体GHSR mRNA阳性表达方面,四磨汤组与模型组比较显著增多(P<0.01),多潘立酮组与模拟组比较增多(P<0.05)。在十二指肠Ghrelin及其受体GHSR mRNA阳性表达方面,两组与模型组比较均升高(P<0.05)。四磨汤组与多潘立酮组相比,上述指标差异均无统计学意义(P>0.05)。
结论
1.四磨汤能显著改善餐后不适综合征FD患者的临床症状,促进胃排空,四磨汤组总疗效与多潘立酮组相当。
2.FD患者血浆Ghrel in的含量显著降低,并与病情严重程度呈负相关。四磨汤可以调节患者血浆Ghrelin水平,稍优于多潘立酮组。
3.FD伴有焦虑、抑郁情况明显高于普通人群,消化不良症状程度与SAS、SDS评分呈正相关。四磨汤可以降低患者SAS、SDS评分,对患者焦虑状况有所改善,但无明显改善抑郁状况的作用。
4.四磨汤能促进慢性应激小鼠胃排空率、小肠推进率,增加不可预知慢性应激小鼠食量、体重,能调节血中MTL、GAS、Ghrel in水平及脑、胃、十二指肠Ghrelin及其受体GHSR mRNA的表达。
5.四磨汤治疗FD的机制可能是通过调节脑肠肽的水平变化,协调脑肠轴的平衡而实现的,这也为中医肝脾相关理论的现代生物学基础是脑肠轴失衡的假说提供了证据。
Objective:
To study the clinical curative effect of Simo Decoction on patients with Postprandial distress syndrome of functional dyspepsia.Explore spirit psychological factors and FD relationship,and from brain gut peptide, brain-gut interaction, brain-gut axis imbalances, discusses the mechanism. Simultaneously,to observe how Simo Decoction affect the chronic stress of gastrointestinal function of mice, gastrointestinal tract and Ghrelin and its receptor expression in brain regions.The thesis provide Chinese medicine, liver and spleen related theory of modern biological basis with brain-gut axis imbalances hypothesis, esearching clinical and experimental basis.
Methods:
1.Patients with postprandial distress syndrome of functional dyspepsia being selected, are randomly divided into treatment group and control group, correspondly given Simo Decoction, and then observe the patients'gastrointestinal emptying-function, symptoms and brain gut peptide, levels of plasma Ghrelin before and after treatment to evaluate their curative effect.
2.Applying the model group of gastrointestinal-emptying impediment by the method of unpredictable chronic stress, next,randomly dividing the mice into model group, Simo Decoction group, domperidone group,and then respectively giving different treatment to observe the situation of animals'carbonpowder-promoting,the residual rate in stomach, to examinate the levels of motilin, gastrin, Ghrelin in serum, Ghrelin and GHSR expression in the stomach, brain and small intestine.
Results:
1. Clinical Research
In two groups of patients with total efficiency compare difference not to have statistical significance (P>0.05)。But the markedly effective rate in treatment group than in control group (P<0.05). For the healing effect of the symptoms of belching and acid reflux, restlessness,regular sigh, constipation, the treatment group is superior to control group(P<0.05) there is no statistical significance between the levels of Ghrelin in plasma and gastric evacuation rate (P>0.05).The comparison between the treatment group after being treated and normal group in respect of the level of Ghrelin (P<0.05),after being treated,the control group is markedly deduced,comparing with normal group (P<0.01). FD patients, with anxiety symptoms and depressive symptoms account for31.67%and25%respectively. Compared with China's general population standard,the grade of SAS and SDS for patients is significantly higher (P<0.01).The number of patients with serious condition accompanying anxiety and depression apparently higher than those with moderate condition. After treatment,the grade of SAS and SDS for patients is decreased and the comparison between the two groups exist no statistical significance (P>0.05). But for the treatment groups, the comparison between after and before treatment in aspect of standard score of SAS P<0.05
2.Experimental Study
Unpredictable chronic stress can set appetite, body mass and the rate of gastric emptying, intestinal propulsive function deducing apparently.(P <0.01)There is no significant pathology change in gastrointestinal tissue. The contents of MTL, GAS, Ghrelin in experimental mice serum(P<0.01) and brain, stomach and duodenum Ghrelin and GHSR mRNA lower distinctly(P<0.01). For the indicators of Simo Decoction group and domperidone group,appetite and weight significantly grow(P<0.01). Gastric emptying, intestinal propulsive function can be restored(P<0.05).The contents of MTL, GAS, Ghrelin of serum cause an increase.The two groups exist no statistical significance (P>0.05). In positive expression aspect of Ghrelin and its receptor GHSR mRNA in brain and gastric tissue, Simo Decoction group compared with the model group increased significantly(P<0.01),domperidone group compared with the model group increase (P<0.05). In positive expression aspect of Ghrelin and its receptor GHSR mRNA in duodenum tissue, Two groups group compared with model are elevated (P<0.05), Simo decoction group and domperidone groups exist no statistical significance (P>0.05).
Conclusion:
1.Simo Decoction can effectively improve symptoms and gastrointestinal-emptying of FD patients.Clinical efficacy of Simo Decoction is equivalent to Domperidone groups.
2.The Ghrelin content of plasma in FD patients is apparently reduced and assumes the inverse correlation with the condition order of severity. Simo Decoction can adjust patients'plasma Ghrelin levels, slightly better than Domperidone group.
3. FD patients with anxiety, depression significantly higher than the normal people, the extent of dyspepsia symptoms and the grade of SAS and SDS are positively correlated. Simo Decoction reduce the grade of SAS and SDS, improve anxiety condition but there is no improvement for depression situations.
4.Simo Decoction not only can promote the rate of gastric emptying in chronic stress of mice and increase appetite,weight for unpredictable chronic stress of mice but also adjust the level of MTL, GAS, Ghrelin of serum and brain, stomach, and small intestine Ghrelin and GHSR mRNA expressions.
5. The possibility of the treatment of FD with the mechanism of Simo Decoction could be achieved by adjusting the level of braingut peptide and balance of brain-gut axis.Furthermore,it provide Chinese medicine, liver and spleen related theory of modern biological basis with brain-gut axis imbalances hypothesis.
引文
[1]Drossman DA. The functional gastrointestinal disorders and the Rome III process [J]. Gastroenterology,2006,130:1377-1390.
[2]平丽,李瑜儿,聂玉强,等.功能性胃肠病患病情况调查[J].实用医学杂志,2003,19(4)：424-426.
[3]Shaih Y,El-Serag H B. The prevalence and risk factors of functional dyspepsia in a multiethnic population in the United States[J]. Am J Gastroenterol,2004,99:2210-2216.
[4]Halder S L, Locke G R 3rd, Schleck C D.Natural history of funstional gastrointestinal disorders:a 12-year longitudinal population-based study [J]. Gastroenterology,2007,133(3):799-807.
[5]张洪领,杨春敏.功能性消化不良的脑肠轴机制研究进展[J].实用医学杂志,2010,26(17)：3265.
[6]付朝伟,徐飚,陈维清,等.中国大城市肠易激综合征和功能性消化不良患者抑郁焦虑现况研究[J].中华消化杂志,2006,26(3)：151-154.
[7]田虹,周汉建,戈兰,等.功能性消化不良患者焦虑和抑郁调查分析[J].广东医学,1999,20(11)：858-859.
[8]郭冬梅.功能性消化不良的精神因索分析及抗抑郁焦虑治疗的临床研究[J].现代医药卫生,2006,22(6)：826.
[9]李岩,王学清,张宁,等.功能性消化不良患者抑郁及焦虑状况分析[J].中华消化杂志,2005,25(7)：428-429.
[10]余珊,曹国木梁,张继美,等.功能性消化不良患者的心理测评及抗抑郁治疗[J].中国临床药学杂志.2003,12(3)：154-157.
[11]柯美云.FD规范化治疗的策略和重要性.临床消化病杂志,2008,20(2)：67.
[12]郑筱萸.中药新药临床研究指导原则(试行).北京：中国医药科技出版社,2002：134.
[13]上海多潘立酮多中心临床研究防作组.多潘立酮片治疗功能性消化不良的临床研究[J].中华消化杂志,2003,23(4)：221.
[14]张明圆.精神科评定量表手册.长沙：湖南科学技术出版社,1993.36～39.
[15]郑筱萸.中药新药临床研究指导原则(试行).北京：中国医药科技出版社,2002：134.
[16]王春芳.抑郁自评量表对1340例正常人评定分析[J].中国神经精神疾病杂志,1986,12(5)：267.
[17]吴文源.焦虑自评量表SAS.上海精神医学,1990,新2卷(增刊·精神评定量表专辑)：44.
[18]李清,高淑丽,王鑫国,等.越鞠保和丸对胃排空及胃液分泌的影响[J].中药药理与临床,2006,22(4)：14-15.
[19]刘柏炎,易健,蔺晓源,等.四磨汤对慢性应激小鼠多巴胺受体D1,D2的影响[J].中国实验方剂学杂志,2011,17(3)：193.
[20]蔡光先,刘柏炎.肝脾相关的现代生物学基础探讨[J].中华中医药学刊,2010,28(7)：1362.
[21]李乾构,周斌,任蜀兵,等.功能性消化不良的辨证论治探析[J].中国中西医结合脾胃杂志,1996,4(2)：115—16.
[22]熊焰,孙泽群,刘继军,等.功能性消化不良与中医证型分布调查[J].中医药学报,2001,29(5)：6-7.
[23]徐敏,卜平,时乐,等.功能性消化不良222例证候病机分析[J].实用中医药杂志,2006,22(4)：247.
[24]卜平.功能性消化不良证候病机分析[J].江苏中医药,2007,39(3)：1-2.
[25]张声生,陈贞.中医药诊疗功能性消化不良若干问题的思考[J].环球中医药,2009,4(2)：245-248.
[26]黄铭涵,黄健,陈琴,等.功能性消化不良中医证型与心理因素的相关性研究[J].中国中西医结合杂志,2010,30(10)：1043.
[27]蒙旭光.功能性消化不良的中医治疗现状及展望[J].河北中医,1997,19(5)：43.
[28]叶仁群,张光奇.疏肝调气法治疗功能性消化不良的探讨[J].吉林中医药,2003,23(1)：1-2.
[29]刘汶,李乾构,柯美云.中西医结合对功能性消化不良的研究[J].中国中西医结合脾胃杂志,1999,7(2)：233.
[30]姚李吉.功能性消化不良伴抑郁焦虑与中医辨证分型的相关性研究[J].中国中西医结合消化杂志,2011,19(3)：183.
[31]朱秀英.从肝脾论治功能性消化不良[J].江西中医药,2005,36(3)：45-46.
[32]TALLEY N J, HOWELL S, POULTON R. The irritable bowel syndrome and psychiatric disorders in thecommunty:is there a link? [J].Am J gastroenterol,2001,96 (4):1072-1074.
[33]Jones M P,Dilley J B,Drossman D, et al. Brain-gut connections in functional GI disorders:anatomic and physiologic relationships [J]. Neurogastroenterology and Motility,2006,18(2):91-103.
[34]Chang L,Sundaresh S,Elliott J, et al. Dysregulation of the hypothalamic-pituitary-adrenal(HPA) axis in irritable bowel syndrome [J].Neurogastroenterology and Motility,2009,21(2):149-159
[35]Bennett EJ, Evans P,scott AM,et al Psychological and Sex features of delayed gut transit in functional gastrointestinal disorders[J]. Gut,2000,46(1):83-88.
[36]蔡顺天,王巍峰,杨云生.ghrelin与功能性消化不良.胃肠病学和肝病学杂志.2011,20(6)：579.
[37]张维,张琍.胃促生长素与功能性消化不良的研究进展.中国现代医药杂志.2011,13(7)：131.
[38]Grundy D,Al-Chaer ED, Aziz Q, et a.l Fundamentals of neurogastroenterology:basic science[J]. Gastroenterology,2006, 130(5):1391-1411.
[39]严灿,邓中炎,吴伟康,等.从心理应激理论研究中医肝主疏泄脏象本质[J].中医杂志,2001,42(1)：8-10.
[40]陈家旭.中医肝本质现代研究进展[J].中国中医基础医学杂志,1998,4(7)：58-61.
[41]陈泽奇,陈国林,胡随瑜,等.肝气郁结证辅助实验诊断指标的初步研究[J].中国现代医学杂志,2001,11(12)：8-9.
[42]聂丹丽.胃动灵对肝郁,脾虚大鼠模型胃肠运动影响的实验研究[J].陕西中 医,2000,21(6)：283-284.
[43]陈芝芸,严茂祥,项柏康.肝郁证大鼠血及结肠组织胃肠激素变化的研究[J].中医杂志,2003,44(2)：131-132.
[44]张惠云,乔明琦,孙丽.肝气郁证模型大鼠下丘脑单胺类神经递质分析[J].中医杂志,2008,49(2)：150.
[45]潘志恒,黄冬梅,阎萍,等.功能性消化不良患者中医证型与胃排空功能关系的研究[J].中医杂志,2002,43(3)：213.
[46]程林,陈斌,蔡宝昌.山药及其麸炒品水提液不同极性部位对脾虚小鼠胃肠功能的影响[J].南京中医药大学学报(自然科学版),2006,3：168.
[47]徐珊,杨青,成信法.乐胃饮对脾气虚实验大鼠胃泌素和胃动素的影响[J].中国医药学报,2004,19(1)：20.
[48]王洪海,谢鸣.复合因素致脾虚证模型大鼠血中胃肠激素含量的变化[J]中国实验方剂学杂志,2006,12(10)：30-35.
[49]刘素梅.实验性脾虚证大鼠胃窦部SP、VIP、CGRP含量的研究[J].首都科技大学学报,1998,19(2)：105-108.
[50]吕琳,陈永红,庞声航,等.壮医药线点灸对脾虚大鼠垂体、下丘脑、胃、肠生长抑素和p-内啡肽的影响[J].上海中医药杂志,2007,3：61.
[51]张洪领,杨春敏.功能性消化不良的脑肠轴机制研究进展[J].实用医学杂,2010,26(17)：3265.
[52]沈骏,诸琦,袁耀宗,等.肠易激综合征患者血浆脑肠肽水平的变化[J].胃肠病学,2005,10(5)：290-292.
[53]郑芝田.胃肠病学.第3版[M].北京：人民卫生出版社,2000,17-23.
[54]周吕,柯美云.胃肠动力学[M].北京：科学出版社,1999：29.
[55]王韶轩.脑肠肽与消化及神经系统基础与临床[M].济南：山东大学出版社，2010：165.
[56]陶琳,张声生,汪红兵,等.健脾理气活血方治疗功能性消化不良临床研究[J].中国中医药信息杂志,2005,12(7)：11-13.
[57]苏娟萍.脾胃病证治对胃肠激素水平影响的临床观察[J].中医药研究,1997,13(2)：20-21.
[58]钟毅,戈焰,饶梅冰.健胃舒分煎颗粒治疗功能性消化不良30例总结[J].湖南中医杂志,2008,24(3)：6-9.
[59]陈欣童,苏峥,黄晓军,等.吗丁啉、雷尼替丁加中药宽中理气汤治疗功能性消化不良的临床对比观察[J].中山大学学报(医学科学版),2004,25(5)：485.
[60]张声生,陶琳,周斌,等.健脾理气消胀方治疗动力障碍型功能性消化不良的临床观察[J].中国中医药信息杂志,2000,7(12)：53.
[61]刘富林,易健,刘柏炎.超微枳术丸对功能性消化不良小鼠胃肠运动及MTL、GAS的影响[J].中国中医急症,2011,20(4)：594-595.
[62]胡学军,黄穗平,邓时贵.健脾理气方对功能性消化不良大鼠胃肠运动功能及胃动素、胃泌素的影响[J].中国实验方剂学杂志,2011,17(8)：214-217.
[63]刘松林,梅国强,赵映前,等.疏肝和胃汤对功能性消化不良大鼠血胃动素和胃泌素的影响[J].中国中西医结合消化杂志,2004,12(4)：198-200.
[64]凌江红,韦连明,张钰琴,等.疏肝理气法对功能性消化不良大鼠下丘脑和胃窦胃泌素、生长抑素表达的影响[J].中国中药杂志,2010,35(22)：3069-3072.
[65]Ozaki K,Yogo K,Sudo H,et al. Effects of mitemcinal (GM-611),an Acid-resistant nonpeptide motilin receptor agonist,on the gastrointestinal contractile activity in conscious dogs[J]. Pharmacology,2007,79 (4):223-235.
[66]尹立新,陈鹏,李琳.胃动素与胃肠动力障碍疾病研究进展[J].中国实用医药,2009,4(5)：238-240.
[67]刘汶,范萌,陈言言,等.柴胡疏肝散对功能性消化不良肝气郁结证患者胃动力及胃肠激素的影响.中医杂志,2010,51(1)：30-33.
[68]KOJIMA M, HOSODA H, DATE Y, et al Ghrelin is a growth-hormone-releasing acylated peptide from stomach [J].Nature,1999,402:656.
[69]Akamizu T, Iwakura H,Ariyasu H,et al.ghrelin and Functional Dyspepsia[J]. International Journal of Peptides,2010,10:1-6
[70]VAN DER LELY AJ, TSCHOP M, HEIMAN ML,et a.1 Biological physiological pathophysiological and pharmacological aspects of ghrelin[J]. Endocrine Reviews,2004,25(3):426.
[71]TANAKA M, HAYASHIDA Y,IGUCHI T,et a.1 Organization of the mouse ghrelin gene and promoter:occurrence of the stomach as an endocrine organ [J].GASEB J,2004,18:439.
[72]Sakata I,Nakamura K, Yamazaki M, et al. Ghrelin-producing cells exist as two types of cells, closed-and opened-type cells in the rat gastrointestinal tract[J]. Peptides,2002,23 (3):531-536.
[73]Date Y,Kojima M,Hosoda H, et al. Ghrelin, a novel growth hormone-releasing acylated peptide,is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and umans [J].Endocrinology,2000,141(11):4255-4261.
[74]Ariyasu H.Takaya K,Tagami T, et al. J Clin Endocrinol Metab,2001; 86:47534-758
[75]Ogiso K,Asakawa A,Amitani H, et al. Ghrelin:a gut hormonal basis of motility regulation and functional dyspepsia [J].Gastroenterol Hepatol,2011,26(3):67-72
[76]Gallas S,Fetissov SO.Ghrelin,appetite and gastricel ectrical stimulation[J].Peptides.2011,32(11):2283-2289.
[77]Asakawa A,Inui A,Kaga T,et al. Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to molitin[J]. Gastrienterology,2001,120(2):337-345.
[78]Shintani M, Ogawa Y,Ebihara K,et al. Ghrelin,an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes lept in action through the act i vat ion of hypothalamic neuropept ide Y/Yl receptor pathway [J].Piabetes,2001,50 (2):227-232.
[79]Wang L,Saint-Pierre DH, Tache Y. Peripheral ghrelin selectively increases Fos expression in neuropeptide Y-syntliesizing neurons in mouse hypothalamic arcuate nucleus [J].Neurosci Lett,2002,325 (1): 47-51.
[80]Shuto Y, Shibasaki T,Otagiri A,et al. Hypothalamic growth hormone secretagogue receptor regulates growth hormone secretion, feeding, and adiposity[J].J Clin Invest,2002,109 (11):1429-1436.
[81]Fukumoto K, Nakahara K, Katayama T, et al. Synergistic action of gastrin and Ghrelin on gastric acid secretion in rats [J]. Biochem Biophys Res Commun,2008,374:60-63.
[82]Sakata I,Nakamura K, Yamazaki M,et al. Ghrelin-producing cellsexist as two types of cells, closed-and opened-type cells in the rat gastrointestinal tract[J]. Peptides,2002,23 (3):531-536.
[83]Nakazato M, Murakami N, Date Y, et al. A role for ghrelin in the central regulation of feeding[J].Nature,2001,409:194-198.
[84]Takamor i K,Mizuta Y,Takeshima F, et al. Relation among plasma ghrelin level, gastric emptying, and psychologic condition in patients with functional dyspepsia[J]. Clin Gastroenterol,2007,41:477-483.
[85]Shindo T, Futagami S, Hiratsuka T, et al. Comparison of gastric emptying and plasma ghrelin levels in patients with functional dyspepsia and nonerosive reflux disease [J]. Digestion 2009,79:65-72.
[86]Arai M,Matsumura T, Tsuchiya N,et al. Rikkunshito improves the symptoms in patients with functional dyspepsia, accompanied by an increase in the level of plasma ghrelin [J]. Hepatogastroenterology. 2012,59(113):62-66.
[87]Tack J,Depoortere I,Bisschops R, et al. Influence of ghrelin on gastric emptying and meal-related symptoms in idiopathic gastroparesis [J]. Aliment Pharmacol Ther,2005,22:847-853.
[88]Suzuki S, Ramos EJ, Goncalves CG, et al. Changes In GI hormones and their effect on gastric emptying and transit times after roux-en-Y gastric bypass in rat model [J]. Surgery,2005,138:283-290.
[89]Rauma J, Spangeus A, E1-Salhy M. Ghrelin cell density in the gastrointestinal tracts of animal models of human diabetes [J].Histol Histopathol,2006,21:1-5.
[90]Tebbe JJ,Mronga S,Tebbe CG,et al.Ghrelin-induced stimulation of colonic propulsion is dependent on hypothalamic neuropeptide Yl and corticotrophin releasing factorlreceptor activation [J]. Neuroendocrinol.2005,17:570-576.
[91]Yuyuan L, Yuqiang N, Weihong S, et a.1 The link between psychosocial factors and functional dyspepsia:an epidemiological study [J]. ChinMed J,2002,115 (7):1082-1084.
[92]Talley NJ, Camilleri M. Epidemiological feature of functional dyspeps ia and irri table bowel syndrome [J].Clinician,1996,14 (1): 7-13
[93]Chang L.Review article:epidemiology and quality of life in functional gastrointestinal disorders [J]. Aliment Pharmacol Ther,2004,20 (Suppl7):31-39
[94]李章,高镇松,林和文.功能性消化不良与心理因素的关系及抗抑郁药辅助治疗效应.中国临床康复,2004,8(24)：4953-4956.
[95]吴晓宁,孙剑,何晓红.功能性消化不良的痛觉阈值测定[J].中国行为医学科学,1996(4)：193-194.
[96]Kurata JH, NogawaAN, ChenYK, eta.1 Dyspepsia in primaray care: perceived causes, reason for improvement, and satisfaction with care [J]. J Family Prac,1997,44 (3):281-288.
[97]侯晓华.开展对功能性消化不良的病理生理研究[J].中华消化杂志,2003,23(2)：69-70
[98]王美峰,林琳,张红杰,等.功能性消化不良患者焦虑、抑郁状况与生活质量的相关性研究[J].南京医科大学学报(自然科学版),2008,28(12)：1677-1679.
[99]Haag S, Senf W, Hauser W, et al. Impairment of heal th-related qual ity of life in functional dyspepsia and chronic liver disease:the influence of depression and anxiety[J].Aliment Pharmacol Ther,2008,27 (7):561-71.
[100]李岩,王学清,张宁,等.功能性消化不良患者抑郁及焦虑状况分析.中华消化杂志,2005,25(7)：428-429.
[101]Hausken T,Svebak S, Wilhelmsen I,et al.Low vagal tone and antral dysmotility in patients with functional dyspepsia. Psychosom Med,1993,55(1):12
[102]Silva L,De 0,Souza A, et a.1 Autonomic function in patients with functional dyspepsia assessed by 24-hour heart rate variability [J]. DigDis Sc, i 2002,47(1):27-31.
[103]Mayer EA,Tillisch K,Bradesi S. Review article:modulation of the brain-gut axis as a therapeutic approach in gastrointestinal disease[J]. Aliment Pharmacol Ther 2006,24 (6):919-933.
[104]Bennett EJ,Evans P,Scott AM,et a.l Psychological and sex features of delayed gut transit in functional gastrointestinal disorders [J]. Gut,2000,46 (1):83-88.
[105]MonnikesH, Tebbe J J, Hi ldebrandt M, et al Role of stress in functional astrointestinal disorders:evidence for stress induced alterations in gastrointestinal motility and sensitivity [J]. DigDis,2001, 19(3):201-211.
[106]曹佳懿,侯晓华.功能性消化不良与精神心理因素[J].中国实用内科杂志,2006,26(7)：538-540.
[107]黄铭涵,黄健,陈琴,等.功能性消化不良中医证型与心理因素的相关性研究[J].世界中医药,2010,5(6)：391-393.
[108]王启之.四磨汤对功能性消化不良患者胃电的影响[J].中国中西医结合脾胃杂志,2000,8(1)：29-31.
[109]裴正月.四磨汤口服液促进剖宫产术后肠功能恢复的临床观察[J].时珍国医国药,2006,6：1042.
[110]官福兰,王如俊,王建华.枳壳及辛弗林对小鼠胃排空、小肠推进功能的影响[J].现代中西医结合杂志,2002,11(11)：1001
[111]Kobayashi W,Miyase T, Sano M,et al.Prolyl endopeptidase inhibitors from the roots of Lindera s trychnifol ia F. Vill[J]. Biol Pharm Bull, 2002,25(8):1049-1053
[112]长春,李宇权,赵素云,等.利胆排石汤的单味药对健康人胆囊运动功能的影响[J].中国中西医结合杂志,1997,17(3)：159
[113]郭喜军,郑陇军,王苏霞,等.槟榔对大鼠胃运动的影响及机制研究.山东中医杂志,2008,27(12)：834-835
[114]刘令安,蔡莹,蔡光先,等.四磨汤对不同机能状态小鼠胃肠运动的影响.中医药导报,2009,15(12)：12-16
[115]易健,刘杰民,蔺晓源,等.四磨汤对腹部非胃肠手术后大鼠胃肠运动的影响[J].中南药学,2010,8(2)：84-86.
[116]蔡光先,蔺晓源,易健,等.四磨汤对慢性应激小鼠胃肠运动及脑内NT.CGRP的影响.中国中医急症,2011,20(2)：251-253.
[117]刘柏炎,易健,陈雪梅,等.四磨汤对慢性应激小鼠胃肠运动及血管活性肠肽表达的影响.中华行为医学与脑科学杂志,2011,20(4)：292-294.
[118]刘杰民,蔺晓源,蔡莹,等.四磨汤对慢性应激小鼠血清Leptin和MTL的影响.中国实验方剂学杂志,2011,17(21)：152-154.
[1]Drossman DA. The functional gastrointestinal disorders and the Rome III process [J]. Gastroenterology,2006,130:1377-1390.
[2]平丽.李瑜儿.聂玉强.等.功能性胃肠病患病情况调查[J].实用医学杂志.2003,19(4)：424-426.
[3]Halder S L, Locke G R 3rd, Schleck C D. Natural history of funstional gastrointestinal disorders:a 12-year longitudinal population based study[J].Castroenterology,2007,133 (3):799-807.
[4]Shaih Y,E1-Serag H B. The prevalence and risk factors of functional dyspepsia in a multiethnic population in the United States[J]. Am J Gastroenterology, 2004,99:2210-2216.
[5]朝伟,徐溅,陈维清,中国大城市肠易激综合征和功能性消化不良患者抑郁焦虑现况研究[J].中华消化杂志,2006,26(3)：151
[6]Talley NJ, Howell S, Poult on R. The irritable bowel syndrome and psychiatric disorders in the community:is there a link? [J]. Am J Gastroenterology,2001, 96(4):1072.
[7]Gnmdy D,Schemann M, Wood J. A tale of two brains, one little and one big[J]。 Neurogastroenterol Mot,2000,12:105
[8]张洪领,杨春敏.功能性消化不良的脑肠轴机制研究进展[J].实用医学杂,2010,26(17)：3265.
[9]沈骏,诸琦,袁耀宗,等.肠易激综合征患者血浆脑肠肽水平的变化[J].胃肠病学,2005,10(5)：290-292.
[10]郑芝田.胃肠病学.第3版[M].北京：人民卫生出版社,2000,17-23.
[11]Ozaki K,Yogo K,Sudo H, et al. Effects of mitemcinal (GM-611),an Acid-resistant nonpcptide motilin receptor agonist,on the gastrointestinal contractile activity in conscious dogs[J]. Pharmacology,2007,79 (4):223-235.
[12]尹立新,陈鹏,李琳.胃动素与胃肠动力障碍疾病研究进展[J].中国实用医药,2009,4(5)：238-240.
[13]刘汶,范萌,陈言言,等.柴胡疏肝散对功能性消化不良肝气郁结证患者胃动力及胃肠激素的影响.中医杂志,2010,51(1)：30-33.
[14]周吕,柯美云.胃肠动力学[M].北京：科学出版社,1999：29.
[15]陶琳,张声生,江红兵,等.健脾理气活血方治疗功能性消化不良临床研究[J].中国中医药信息杂志,2005,12(7)：11-13.
[16]刘富林,易健,刘柏炎.超微枳术九对功能性消化不良小鼠胃肠运动及MTL、GAS的影响[J].中国中医急症,2011,20(4)：594-595.
[17]Ilichiewicz AN, Feltrin KL, Horowitz M, et al. Functional dyspepsia is associated with a greater symptomatic response to fat but not carbohydrate, increased fasting and postprandial CCK, and diminished PYY[J]. Am J Gastroenterol,2008,103: 2613-2623.
[18]Parkman HP, Camilleri M, Far rug i a G, et al. Gastropares is and functional dyspepsia: excerpts from the AGA/ANMS meet ing[J]. Neurogastroenterol Motil,2010,22:113-133.
[19]Dizdar V,Spiller R, Singh G,et al. Relative importance of abnormalities of CCK and 5-HT(serotonin)in Giardia induced post infectious irritable bowel syndrome and functional dyspepsia[J]. Aliment Pharmacol Ther,2010,31:883-891.
[20]刘杰民,蔡光先,刘柏炎.功能性消化不良的胃肠激素变化及中药调节的研究进展[J].湖南中医杂志,2009,25(6)：117-118.
[21]Hernandez DE. The role of brain peptides in the pathogenesis of experimental stress gastric ulcers[J]. Ann NY Acad Sci,1990,597:28-35.
[22]Sako F, Marui S, lnatomi N, et al. EM574, an crythromycin derivative, improves delayed gastric emptying of semi-solid meals in consciousdogs[J]. Eur J Pharmacol, 2000, 395:165-172.
[23]李启祥,侯晓华.降钙素基因相关肽与胃肠运动的调节[J].国外医学消化系疾病分册,2000,20(1)：20-23.
[24]Yong-Xuang , Chih-Haolee, Sambath,et al. Peroxisome-proliferators activated receptor activates fat metabolism to prevent obesity[J]. Cell, 2003, 18(113): 159-170.
[25]刘满君,贾利辉,陈霄.通腑方灌肠对腹部术后MTL. CGRP的影响及临床疗效的研究[J].河北中医药学报,2008,32(4)：14-16.
[26]陈莹,刘文天.胃肠神经介质在功能性消化不良发病中的作用[J].医学综述,2008,14(4)：486-488.
[27]1. Nyren 0, Adami HO, Bergs trom R, et a 1. Basal and food st imulatcd levels of gastr in and pancreatic polypeptide in nonulcer dyspepsia and duodenal ulcer[J]. Scand J Gastroenterol, 1986, 21(4): 471-477.
[28]Zhang H, Han T, Sun L N, etal. Regulative effects of cssen t ial oil from At racty lodes Ian cea on delayed gastric emptying in stress induced rats [J]. Phytoraedicine, 2008, 15(8): 602-611.
[29]KOJIMAM, HOSODA H, DATE Y, etal. Ghrel in is a growth-hormone-releasing acylated peptide from stomach [J]. Nature,1999,402: 656.
[30]Saka ta I, Nakamura K, Yamazaki M, et al. Ghrel in-producing eel Is exist as two types of eel Is,closed-and opened-type cells in the rat gastrointestinal tract [J]. Peptides,2002, 23(3): 531-536.
[31]DateY, Kojima M, Hosoda H, et al. Ghrel in, a novel growth hormone-re leasingacy la ted peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and umans [J]. Endocrinology,2000, 141 (11): 4255-4261.
[32]Asakawa A,Inui A, Kaga T, et al. Ghrelin is an appeti te-stimulatory signal from stomach with structural resemblance to molitin[J]. Gastrienterology, 2001, 120(2): 337-345.
133]Shintani M, Ogawa Y, Ebihara K, et al.Ghrclin, an endogenous growth hormo-nc secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Yl receptor pathway [J]. Piabetes, 2001, 50(2): 227-232.
[34]Wang L, Saint-Pierre DH, Tache Y. Peripheral ghrelin selectively increases Fos expression in neuropept ide Y-synthes izing neurons in mouse hypothalamic a-rcuate nucleus [J]. Neurosci Lett,2002, 325 (1):47-51.
[35]ShutoY, ShibasakiT, Otagiri A, et al. llypothalamic growth hormone secrct-agoguc receptor regulates growth hormone secretion, feeding, and adiposity [J]. J Clin Invest, 2002, 109(11): 1429-1436.
[36]Fukumoto K, Nakahara K, Katayama T,ct a 1.Synergistic action of gastrin and Ghrelin on gastric acid secretion in rats [J]. Biochcm Biophys Res Commun, 2008, 374: 60-63.
[37]Sakata I, Nakamura K, Yamazaki M, et al. Ghrel in-producing ecl 1 sexist as two types of cells,closed-and opened-type cells in the rat gastrointestinal tract [J]. Peptides,2002,23(3):531-536.
[38]Nakazato M, Murakami N, Date Y, et al. A role for ghrel in in the central regulation of feeding. Nature,2001,409:194-198.
[39]Takamori K,Mizuta Y,Takeshima F, et al. Relation among plasma ghrelin level, gastric emptying, and psychologic condition in patients with funct ional dyspepsia. J Clin Gastroenterol,2007,41:477-483.
[40]Shindo T, Futagami S, Hiratsuka T, et al. Comparison of gastric emptying and plasma ghrelin levels in patients with functional dyspepsia and nonerosive reflux disease[J]. Digestion 2009,79:65-72.
[41]Arai M,Matsumura T,Tsuchiya N,et al.Rikkunshito improves the symptoms in patients with functional dyspepsia, accompanied by an increase in the level of plasma ghrelin[J]. Hepatogastroenterology.2012,59 (113):62-66.
[42]Tack J, Depoortere I, Bisschops R, et al. Influence of ghrelin on gastric emptying and meal-related symptoms in idiopathic gastroparesis[J]. Aliment Pharmacol Ther,2005,22:847-853.
[43]Tebbe JJ,Mronga S,Tebbe CG,et al. Ghrelin-induced stimulation of colonic propulsion is dependent on hypothalamic neuropeptide Y1-and corticotrophin releasing factorlreceptor activation. J Neuroendocrinol.2005,17:570-576.
[2]平丽,李瑜儿,聂玉强,等.功能性胃肠病患病情况调查[J].实用医学杂志,2003,19(4)：424-426.
[3]Shaih Y,El-Serag H B. The prevalence and risk factors of functional dyspepsia in a multiethnic population in the United States[J]. Am J Gastroenterol,2004,99:2210-2216.
[4]Halder S L, Locke G R 3rd, Schleck C D.Natural history of funstional gastrointestinal disorders:a 12-year longitudinal population-based study [J]. Gastroenterology,2007,133(3):799-807.
[5]张洪领,杨春敏.功能性消化不良的脑肠轴机制研究进展[J].实用医学杂志,2010,26(17)：3265.
[6]付朝伟,徐飚,陈维清,等.中国大城市肠易激综合征和功能性消化不良患者抑郁焦虑现况研究[J].中华消化杂志,2006,26(3)：151-154.
[7]田虹,周汉建,戈兰,等.功能性消化不良患者焦虑和抑郁调查分析[J].广东医学,1999,20(11)：858-859.
[8]郭冬梅.功能性消化不良的精神因索分析及抗抑郁焦虑治疗的临床研究[J].现代医药卫生,2006,22(6)：826.
[9]李岩,王学清,张宁,等.功能性消化不良患者抑郁及焦虑状况分析[J].中华消化杂志,2005,25(7)：428-429.
[10]余珊,曹国木梁,张继美,等.功能性消化不良患者的心理测评及抗抑郁治疗[J].中国临床药学杂志.2003,12(3)：154-157.
[11]柯美云.FD规范化治疗的策略和重要性.临床消化病杂志,2008,20(2)：67.
[12]郑筱萸.中药新药临床研究指导原则(试行).北京：中国医药科技出版社,2002：134.
[13]上海多潘立酮多中心临床研究防作组.多潘立酮片治疗功能性消化不良的临床研究[J].中华消化杂志,2003,23(4)：221.
[14]张明圆.精神科评定量表手册.长沙：湖南科学技术出版社,1993.36～39.
[15]郑筱萸.中药新药临床研究指导原则(试行).北京：中国医药科技出版社,2002：134.
[16]王春芳.抑郁自评量表对1340例正常人评定分析[J].中国神经精神疾病杂志,1986,12(5)：267.
[17]吴文源.焦虑自评量表SAS.上海精神医学,1990,新2卷(增刊·精神评定量表专辑)：44.
[18]李清,高淑丽,王鑫国,等.越鞠保和丸对胃排空及胃液分泌的影响[J].中药药理与临床,2006,22(4)：14-15.
[19]刘柏炎,易健,蔺晓源,等.四磨汤对慢性应激小鼠多巴胺受体D1,D2的影响[J].中国实验方剂学杂志,2011,17(3)：193.
[20]蔡光先,刘柏炎.肝脾相关的现代生物学基础探讨[J].中华中医药学刊,2010,28(7)：1362.
[21]李乾构,周斌,任蜀兵,等.功能性消化不良的辨证论治探析[J].中国中西医结合脾胃杂志,1996,4(2)：115—16.
[22]熊焰,孙泽群,刘继军,等.功能性消化不良与中医证型分布调查[J].中医药学报,2001,29(5)：6-7.
[23]徐敏,卜平,时乐,等.功能性消化不良222例证候病机分析[J].实用中医药杂志,2006,22(4)：247.
[24]卜平.功能性消化不良证候病机分析[J].江苏中医药,2007,39(3)：1-2.
[25]张声生,陈贞.中医药诊疗功能性消化不良若干问题的思考[J].环球中医药,2009,4(2)：245-248.
[26]黄铭涵,黄健,陈琴,等.功能性消化不良中医证型与心理因素的相关性研究[J].中国中西医结合杂志,2010,30(10)：1043.
[27]蒙旭光.功能性消化不良的中医治疗现状及展望[J].河北中医,1997,19(5)：43.
[28]叶仁群,张光奇.疏肝调气法治疗功能性消化不良的探讨[J].吉林中医药,2003,23(1)：1-2.
[29]刘汶,李乾构,柯美云.中西医结合对功能性消化不良的研究[J].中国中西医结合脾胃杂志,1999,7(2)：233.
[30]姚李吉.功能性消化不良伴抑郁焦虑与中医辨证分型的相关性研究[J].中国中西医结合消化杂志,2011,19(3)：183.
[31]朱秀英.从肝脾论治功能性消化不良[J].江西中医药,2005,36(3)：45-46.
[32]TALLEY N J, HOWELL S, POULTON R. The irritable bowel syndrome and psychiatric disorders in thecommunty:is there a link? [J].Am J gastroenterol,2001,96 (4):1072-1074.
[33]Jones M P,Dilley J B,Drossman D, et al. Brain-gut connections in functional GI disorders:anatomic and physiologic relationships [J]. Neurogastroenterology and Motility,2006,18(2):91-103.
[34]Chang L,Sundaresh S,Elliott J, et al. Dysregulation of the hypothalamic-pituitary-adrenal(HPA) axis in irritable bowel syndrome [J].Neurogastroenterology and Motility,2009,21(2):149-159
[35]Bennett EJ, Evans P,scott AM,et al Psychological and Sex features of delayed gut transit in functional gastrointestinal disorders[J]. Gut,2000,46(1):83-88.
[36]蔡顺天,王巍峰,杨云生.ghrelin与功能性消化不良.胃肠病学和肝病学杂志.2011,20(6)：579.
[37]张维,张琍.胃促生长素与功能性消化不良的研究进展.中国现代医药杂志.2011,13(7)：131.
[38]Grundy D,Al-Chaer ED, Aziz Q, et a.l Fundamentals of neurogastroenterology:basic science[J]. Gastroenterology,2006, 130(5):1391-1411.
[39]严灿,邓中炎,吴伟康,等.从心理应激理论研究中医肝主疏泄脏象本质[J].中医杂志,2001,42(1)：8-10.
[40]陈家旭.中医肝本质现代研究进展[J].中国中医基础医学杂志,1998,4(7)：58-61.
[41]陈泽奇,陈国林,胡随瑜,等.肝气郁结证辅助实验诊断指标的初步研究[J].中国现代医学杂志,2001,11(12)：8-9.
[42]聂丹丽.胃动灵对肝郁,脾虚大鼠模型胃肠运动影响的实验研究[J].陕西中 医,2000,21(6)：283-284.
[43]陈芝芸,严茂祥,项柏康.肝郁证大鼠血及结肠组织胃肠激素变化的研究[J].中医杂志,2003,44(2)：131-132.
[44]张惠云,乔明琦,孙丽.肝气郁证模型大鼠下丘脑单胺类神经递质分析[J].中医杂志,2008,49(2)：150.
[45]潘志恒,黄冬梅,阎萍,等.功能性消化不良患者中医证型与胃排空功能关系的研究[J].中医杂志,2002,43(3)：213.
[46]程林,陈斌,蔡宝昌.山药及其麸炒品水提液不同极性部位对脾虚小鼠胃肠功能的影响[J].南京中医药大学学报(自然科学版),2006,3：168.
[47]徐珊,杨青,成信法.乐胃饮对脾气虚实验大鼠胃泌素和胃动素的影响[J].中国医药学报,2004,19(1)：20.
[48]王洪海,谢鸣.复合因素致脾虚证模型大鼠血中胃肠激素含量的变化[J]中国实验方剂学杂志,2006,12(10)：30-35.
[49]刘素梅.实验性脾虚证大鼠胃窦部SP、VIP、CGRP含量的研究[J].首都科技大学学报,1998,19(2)：105-108.
[50]吕琳,陈永红,庞声航,等.壮医药线点灸对脾虚大鼠垂体、下丘脑、胃、肠生长抑素和p-内啡肽的影响[J].上海中医药杂志,2007,3：61.
[51]张洪领,杨春敏.功能性消化不良的脑肠轴机制研究进展[J].实用医学杂,2010,26(17)：3265.
[52]沈骏,诸琦,袁耀宗,等.肠易激综合征患者血浆脑肠肽水平的变化[J].胃肠病学,2005,10(5)：290-292.
[53]郑芝田.胃肠病学.第3版[M].北京：人民卫生出版社,2000,17-23.
[54]周吕,柯美云.胃肠动力学[M].北京：科学出版社,1999：29.
[55]王韶轩.脑肠肽与消化及神经系统基础与临床[M].济南：山东大学出版社，2010：165.
[56]陶琳,张声生,汪红兵,等.健脾理气活血方治疗功能性消化不良临床研究[J].中国中医药信息杂志,2005,12(7)：11-13.
[57]苏娟萍.脾胃病证治对胃肠激素水平影响的临床观察[J].中医药研究,1997,13(2)：20-21.
[58]钟毅,戈焰,饶梅冰.健胃舒分煎颗粒治疗功能性消化不良30例总结[J].湖南中医杂志,2008,24(3)：6-9.
[59]陈欣童,苏峥,黄晓军,等.吗丁啉、雷尼替丁加中药宽中理气汤治疗功能性消化不良的临床对比观察[J].中山大学学报(医学科学版),2004,25(5)：485.
[60]张声生,陶琳,周斌,等.健脾理气消胀方治疗动力障碍型功能性消化不良的临床观察[J].中国中医药信息杂志,2000,7(12)：53.
[61]刘富林,易健,刘柏炎.超微枳术丸对功能性消化不良小鼠胃肠运动及MTL、GAS的影响[J].中国中医急症,2011,20(4)：594-595.
[62]胡学军,黄穗平,邓时贵.健脾理气方对功能性消化不良大鼠胃肠运动功能及胃动素、胃泌素的影响[J].中国实验方剂学杂志,2011,17(8)：214-217.
[63]刘松林,梅国强,赵映前,等.疏肝和胃汤对功能性消化不良大鼠血胃动素和胃泌素的影响[J].中国中西医结合消化杂志,2004,12(4)：198-200.
[64]凌江红,韦连明,张钰琴,等.疏肝理气法对功能性消化不良大鼠下丘脑和胃窦胃泌素、生长抑素表达的影响[J].中国中药杂志,2010,35(22)：3069-3072.
[65]Ozaki K,Yogo K,Sudo H,et al. Effects of mitemcinal (GM-611),an Acid-resistant nonpeptide motilin receptor agonist,on the gastrointestinal contractile activity in conscious dogs[J]. Pharmacology,2007,79 (4):223-235.
[66]尹立新,陈鹏,李琳.胃动素与胃肠动力障碍疾病研究进展[J].中国实用医药,2009,4(5)：238-240.
[67]刘汶,范萌,陈言言,等.柴胡疏肝散对功能性消化不良肝气郁结证患者胃动力及胃肠激素的影响.中医杂志,2010,51(1)：30-33.
[68]KOJIMA M, HOSODA H, DATE Y, et al Ghrelin is a growth-hormone-releasing acylated peptide from stomach [J].Nature,1999,402:656.
[69]Akamizu T, Iwakura H,Ariyasu H,et al.ghrelin and Functional Dyspepsia[J]. International Journal of Peptides,2010,10:1-6
[70]VAN DER LELY AJ, TSCHOP M, HEIMAN ML,et a.1 Biological physiological pathophysiological and pharmacological aspects of ghrelin[J]. Endocrine Reviews,2004,25(3):426.
[71]TANAKA M, HAYASHIDA Y,IGUCHI T,et a.1 Organization of the mouse ghrelin gene and promoter:occurrence of the stomach as an endocrine organ [J].GASEB J,2004,18:439.
[72]Sakata I,Nakamura K, Yamazaki M, et al. Ghrelin-producing cells exist as two types of cells, closed-and opened-type cells in the rat gastrointestinal tract[J]. Peptides,2002,23 (3):531-536.
[73]Date Y,Kojima M,Hosoda H, et al. Ghrelin, a novel growth hormone-releasing acylated peptide,is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and umans [J].Endocrinology,2000,141(11):4255-4261.
[74]Ariyasu H.Takaya K,Tagami T, et al. J Clin Endocrinol Metab,2001; 86:47534-758
[75]Ogiso K,Asakawa A,Amitani H, et al. Ghrelin:a gut hormonal basis of motility regulation and functional dyspepsia [J].Gastroenterol Hepatol,2011,26(3):67-72
[76]Gallas S,Fetissov SO.Ghrelin,appetite and gastricel ectrical stimulation[J].Peptides.2011,32(11):2283-2289.
[77]Asakawa A,Inui A,Kaga T,et al. Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to molitin[J]. Gastrienterology,2001,120(2):337-345.
[78]Shintani M, Ogawa Y,Ebihara K,et al. Ghrelin,an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes lept in action through the act i vat ion of hypothalamic neuropept ide Y/Yl receptor pathway [J].Piabetes,2001,50 (2):227-232.
[79]Wang L,Saint-Pierre DH, Tache Y. Peripheral ghrelin selectively increases Fos expression in neuropeptide Y-syntliesizing neurons in mouse hypothalamic arcuate nucleus [J].Neurosci Lett,2002,325 (1): 47-51.
[80]Shuto Y, Shibasaki T,Otagiri A,et al. Hypothalamic growth hormone secretagogue receptor regulates growth hormone secretion, feeding, and adiposity[J].J Clin Invest,2002,109 (11):1429-1436.
[81]Fukumoto K, Nakahara K, Katayama T, et al. Synergistic action of gastrin and Ghrelin on gastric acid secretion in rats [J]. Biochem Biophys Res Commun,2008,374:60-63.
[82]Sakata I,Nakamura K, Yamazaki M,et al. Ghrelin-producing cellsexist as two types of cells, closed-and opened-type cells in the rat gastrointestinal tract[J]. Peptides,2002,23 (3):531-536.
[83]Nakazato M, Murakami N, Date Y, et al. A role for ghrelin in the central regulation of feeding[J].Nature,2001,409:194-198.
[84]Takamor i K,Mizuta Y,Takeshima F, et al. Relation among plasma ghrelin level, gastric emptying, and psychologic condition in patients with functional dyspepsia[J]. Clin Gastroenterol,2007,41:477-483.
[85]Shindo T, Futagami S, Hiratsuka T, et al. Comparison of gastric emptying and plasma ghrelin levels in patients with functional dyspepsia and nonerosive reflux disease [J]. Digestion 2009,79:65-72.
[86]Arai M,Matsumura T, Tsuchiya N,et al. Rikkunshito improves the symptoms in patients with functional dyspepsia, accompanied by an increase in the level of plasma ghrelin [J]. Hepatogastroenterology. 2012,59(113):62-66.
[87]Tack J,Depoortere I,Bisschops R, et al. Influence of ghrelin on gastric emptying and meal-related symptoms in idiopathic gastroparesis [J]. Aliment Pharmacol Ther,2005,22:847-853.
[88]Suzuki S, Ramos EJ, Goncalves CG, et al. Changes In GI hormones and their effect on gastric emptying and transit times after roux-en-Y gastric bypass in rat model [J]. Surgery,2005,138:283-290.
[89]Rauma J, Spangeus A, E1-Salhy M. Ghrelin cell density in the gastrointestinal tracts of animal models of human diabetes [J].Histol Histopathol,2006,21:1-5.
[90]Tebbe JJ,Mronga S,Tebbe CG,et al.Ghrelin-induced stimulation of colonic propulsion is dependent on hypothalamic neuropeptide Yl and corticotrophin releasing factorlreceptor activation [J]. Neuroendocrinol.2005,17:570-576.
[91]Yuyuan L, Yuqiang N, Weihong S, et a.1 The link between psychosocial factors and functional dyspepsia:an epidemiological study [J]. ChinMed J,2002,115 (7):1082-1084.
[92]Talley NJ, Camilleri M. Epidemiological feature of functional dyspeps ia and irri table bowel syndrome [J].Clinician,1996,14 (1): 7-13
[93]Chang L.Review article:epidemiology and quality of life in functional gastrointestinal disorders [J]. Aliment Pharmacol Ther,2004,20 (Suppl7):31-39
[94]李章,高镇松,林和文.功能性消化不良与心理因素的关系及抗抑郁药辅助治疗效应.中国临床康复,2004,8(24)：4953-4956.
[95]吴晓宁,孙剑,何晓红.功能性消化不良的痛觉阈值测定[J].中国行为医学科学,1996(4)：193-194.
[96]Kurata JH, NogawaAN, ChenYK, eta.1 Dyspepsia in primaray care: perceived causes, reason for improvement, and satisfaction with care [J]. J Family Prac,1997,44 (3):281-288.
[97]侯晓华.开展对功能性消化不良的病理生理研究[J].中华消化杂志,2003,23(2)：69-70
[98]王美峰,林琳,张红杰,等.功能性消化不良患者焦虑、抑郁状况与生活质量的相关性研究[J].南京医科大学学报(自然科学版),2008,28(12)：1677-1679.
[99]Haag S, Senf W, Hauser W, et al. Impairment of heal th-related qual ity of life in functional dyspepsia and chronic liver disease:the influence of depression and anxiety[J].Aliment Pharmacol Ther,2008,27 (7):561-71.
[100]李岩,王学清,张宁,等.功能性消化不良患者抑郁及焦虑状况分析.中华消化杂志,2005,25(7)：428-429.
[101]Hausken T,Svebak S, Wilhelmsen I,et al.Low vagal tone and antral dysmotility in patients with functional dyspepsia. Psychosom Med,1993,55(1):12
[102]Silva L,De 0,Souza A, et a.1 Autonomic function in patients with functional dyspepsia assessed by 24-hour heart rate variability [J]. DigDis Sc, i 2002,47(1):27-31.
[103]Mayer EA,Tillisch K,Bradesi S. Review article:modulation of the brain-gut axis as a therapeutic approach in gastrointestinal disease[J]. Aliment Pharmacol Ther 2006,24 (6):919-933.
[104]Bennett EJ,Evans P,Scott AM,et a.l Psychological and sex features of delayed gut transit in functional gastrointestinal disorders [J]. Gut,2000,46 (1):83-88.
[105]MonnikesH, Tebbe J J, Hi ldebrandt M, et al Role of stress in functional astrointestinal disorders:evidence for stress induced alterations in gastrointestinal motility and sensitivity [J]. DigDis,2001, 19(3):201-211.
[106]曹佳懿,侯晓华.功能性消化不良与精神心理因素[J].中国实用内科杂志,2006,26(7)：538-540.
[107]黄铭涵,黄健,陈琴,等.功能性消化不良中医证型与心理因素的相关性研究[J].世界中医药,2010,5(6)：391-393.
[108]王启之.四磨汤对功能性消化不良患者胃电的影响[J].中国中西医结合脾胃杂志,2000,8(1)：29-31.
[109]裴正月.四磨汤口服液促进剖宫产术后肠功能恢复的临床观察[J].时珍国医国药,2006,6：1042.
[110]官福兰,王如俊,王建华.枳壳及辛弗林对小鼠胃排空、小肠推进功能的影响[J].现代中西医结合杂志,2002,11(11)：1001
[111]Kobayashi W,Miyase T, Sano M,et al.Prolyl endopeptidase inhibitors from the roots of Lindera s trychnifol ia F. Vill[J]. Biol Pharm Bull, 2002,25(8):1049-1053
[112]长春,李宇权,赵素云,等.利胆排石汤的单味药对健康人胆囊运动功能的影响[J].中国中西医结合杂志,1997,17(3)：159
[113]郭喜军,郑陇军,王苏霞,等.槟榔对大鼠胃运动的影响及机制研究.山东中医杂志,2008,27(12)：834-835
[114]刘令安,蔡莹,蔡光先,等.四磨汤对不同机能状态小鼠胃肠运动的影响.中医药导报,2009,15(12)：12-16
[115]易健,刘杰民,蔺晓源,等.四磨汤对腹部非胃肠手术后大鼠胃肠运动的影响[J].中南药学,2010,8(2)：84-86.
[116]蔡光先,蔺晓源,易健,等.四磨汤对慢性应激小鼠胃肠运动及脑内NT.CGRP的影响.中国中医急症,2011,20(2)：251-253.
[117]刘柏炎,易健,陈雪梅,等.四磨汤对慢性应激小鼠胃肠运动及血管活性肠肽表达的影响.中华行为医学与脑科学杂志,2011,20(4)：292-294.
[118]刘杰民,蔺晓源,蔡莹,等.四磨汤对慢性应激小鼠血清Leptin和MTL的影响.中国实验方剂学杂志,2011,17(21)：152-154.
[1]Drossman DA. The functional gastrointestinal disorders and the Rome III process [J]. Gastroenterology,2006,130:1377-1390.
[2]平丽.李瑜儿.聂玉强.等.功能性胃肠病患病情况调查[J].实用医学杂志.2003,19(4)：424-426.
[3]Halder S L, Locke G R 3rd, Schleck C D. Natural history of funstional gastrointestinal disorders:a 12-year longitudinal population based study[J].Castroenterology,2007,133 (3):799-807.
[4]Shaih Y,E1-Serag H B. The prevalence and risk factors of functional dyspepsia in a multiethnic population in the United States[J]. Am J Gastroenterology, 2004,99:2210-2216.
[5]朝伟,徐溅,陈维清,中国大城市肠易激综合征和功能性消化不良患者抑郁焦虑现况研究[J].中华消化杂志,2006,26(3)：151
[6]Talley NJ, Howell S, Poult on R. The irritable bowel syndrome and psychiatric disorders in the community:is there a link? [J]. Am J Gastroenterology,2001, 96(4):1072.
[7]Gnmdy D,Schemann M, Wood J. A tale of two brains, one little and one big[J]。 Neurogastroenterol Mot,2000,12:105
[8]张洪领,杨春敏.功能性消化不良的脑肠轴机制研究进展[J].实用医学杂,2010,26(17)：3265.
[9]沈骏,诸琦,袁耀宗,等.肠易激综合征患者血浆脑肠肽水平的变化[J].胃肠病学,2005,10(5)：290-292.
[10]郑芝田.胃肠病学.第3版[M].北京：人民卫生出版社,2000,17-23.
[11]Ozaki K,Yogo K,Sudo H, et al. Effects of mitemcinal (GM-611),an Acid-resistant nonpcptide motilin receptor agonist,on the gastrointestinal contractile activity in conscious dogs[J]. Pharmacology,2007,79 (4):223-235.
[12]尹立新,陈鹏,李琳.胃动素与胃肠动力障碍疾病研究进展[J].中国实用医药,2009,4(5)：238-240.
[13]刘汶,范萌,陈言言,等.柴胡疏肝散对功能性消化不良肝气郁结证患者胃动力及胃肠激素的影响.中医杂志,2010,51(1)：30-33.
[14]周吕,柯美云.胃肠动力学[M].北京：科学出版社,1999：29.
[15]陶琳,张声生,江红兵,等.健脾理气活血方治疗功能性消化不良临床研究[J].中国中医药信息杂志,2005,12(7)：11-13.
[16]刘富林,易健,刘柏炎.超微枳术九对功能性消化不良小鼠胃肠运动及MTL、GAS的影响[J].中国中医急症,2011,20(4)：594-595.
[17]Ilichiewicz AN, Feltrin KL, Horowitz M, et al. Functional dyspepsia is associated with a greater symptomatic response to fat but not carbohydrate, increased fasting and postprandial CCK, and diminished PYY[J]. Am J Gastroenterol,2008,103: 2613-2623.
[18]Parkman HP, Camilleri M, Far rug i a G, et al. Gastropares is and functional dyspepsia: excerpts from the AGA/ANMS meet ing[J]. Neurogastroenterol Motil,2010,22:113-133.
[19]Dizdar V,Spiller R, Singh G,et al. Relative importance of abnormalities of CCK and 5-HT(serotonin)in Giardia induced post infectious irritable bowel syndrome and functional dyspepsia[J]. Aliment Pharmacol Ther,2010,31:883-891.
[20]刘杰民,蔡光先,刘柏炎.功能性消化不良的胃肠激素变化及中药调节的研究进展[J].湖南中医杂志,2009,25(6)：117-118.
[21]Hernandez DE. The role of brain peptides in the pathogenesis of experimental stress gastric ulcers[J]. Ann NY Acad Sci,1990,597:28-35.
[22]Sako F, Marui S, lnatomi N, et al. EM574, an crythromycin derivative, improves delayed gastric emptying of semi-solid meals in consciousdogs[J]. Eur J Pharmacol, 2000, 395:165-172.
[23]李启祥,侯晓华.降钙素基因相关肽与胃肠运动的调节[J].国外医学消化系疾病分册,2000,20(1)：20-23.
[24]Yong-Xuang , Chih-Haolee, Sambath,et al. Peroxisome-proliferators activated receptor activates fat metabolism to prevent obesity[J]. Cell, 2003, 18(113): 159-170.
[25]刘满君,贾利辉,陈霄.通腑方灌肠对腹部术后MTL. CGRP的影响及临床疗效的研究[J].河北中医药学报,2008,32(4)：14-16.
[26]陈莹,刘文天.胃肠神经介质在功能性消化不良发病中的作用[J].医学综述,2008,14(4)：486-488.
[27]1. Nyren 0, Adami HO, Bergs trom R, et a 1. Basal and food st imulatcd levels of gastr in and pancreatic polypeptide in nonulcer dyspepsia and duodenal ulcer[J]. Scand J Gastroenterol, 1986, 21(4): 471-477.
[28]Zhang H, Han T, Sun L N, etal. Regulative effects of cssen t ial oil from At racty lodes Ian cea on delayed gastric emptying in stress induced rats [J]. Phytoraedicine, 2008, 15(8): 602-611.
[29]KOJIMAM, HOSODA H, DATE Y, etal. Ghrel in is a growth-hormone-releasing acylated peptide from stomach [J]. Nature,1999,402: 656.
[30]Saka ta I, Nakamura K, Yamazaki M, et al. Ghrel in-producing eel Is exist as two types of eel Is,closed-and opened-type cells in the rat gastrointestinal tract [J]. Peptides,2002, 23(3): 531-536.
[31]DateY, Kojima M, Hosoda H, et al. Ghrel in, a novel growth hormone-re leasingacy la ted peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and umans [J]. Endocrinology,2000, 141 (11): 4255-4261.
[32]Asakawa A,Inui A, Kaga T, et al. Ghrelin is an appeti te-stimulatory signal from stomach with structural resemblance to molitin[J]. Gastrienterology, 2001, 120(2): 337-345.
133]Shintani M, Ogawa Y, Ebihara K, et al.Ghrclin, an endogenous growth hormo-nc secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Yl receptor pathway [J]. Piabetes, 2001, 50(2): 227-232.
[34]Wang L, Saint-Pierre DH, Tache Y. Peripheral ghrelin selectively increases Fos expression in neuropept ide Y-synthes izing neurons in mouse hypothalamic a-rcuate nucleus [J]. Neurosci Lett,2002, 325 (1):47-51.
[35]ShutoY, ShibasakiT, Otagiri A, et al. llypothalamic growth hormone secrct-agoguc receptor regulates growth hormone secretion, feeding, and adiposity [J]. J Clin Invest, 2002, 109(11): 1429-1436.
[36]Fukumoto K, Nakahara K, Katayama T,ct a 1.Synergistic action of gastrin and Ghrelin on gastric acid secretion in rats [J]. Biochcm Biophys Res Commun, 2008, 374: 60-63.
[37]Sakata I, Nakamura K, Yamazaki M, et al. Ghrel in-producing ecl 1 sexist as two types of cells,closed-and opened-type cells in the rat gastrointestinal tract [J]. Peptides,2002,23(3):531-536.
[38]Nakazato M, Murakami N, Date Y, et al. A role for ghrel in in the central regulation of feeding. Nature,2001,409:194-198.
[39]Takamori K,Mizuta Y,Takeshima F, et al. Relation among plasma ghrelin level, gastric emptying, and psychologic condition in patients with funct ional dyspepsia. J Clin Gastroenterol,2007,41:477-483.
[40]Shindo T, Futagami S, Hiratsuka T, et al. Comparison of gastric emptying and plasma ghrelin levels in patients with functional dyspepsia and nonerosive reflux disease[J]. Digestion 2009,79:65-72.
[41]Arai M,Matsumura T,Tsuchiya N,et al.Rikkunshito improves the symptoms in patients with functional dyspepsia, accompanied by an increase in the level of plasma ghrelin[J]. Hepatogastroenterology.2012,59 (113):62-66.
[42]Tack J, Depoortere I, Bisschops R, et al. Influence of ghrelin on gastric emptying and meal-related symptoms in idiopathic gastroparesis[J]. Aliment Pharmacol Ther,2005,22:847-853.
[43]Tebbe JJ,Mronga S,Tebbe CG,et al. Ghrelin-induced stimulation of colonic propulsion is dependent on hypothalamic neuropeptide Y1-and corticotrophin releasing factorlreceptor activation. J Neuroendocrinol.2005,17:570-576.
© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号 地址：北京市海淀区学院路29号 邮编：100083 电话：办公室：(+86 10)66554848；文献借阅、咨询服务、科技查新：66554700 |